BioData appoints new chief executive
September 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Louis Culot, biodata, culot
Digital science portfolio firm BioData that produces web-based research and lab management service Labguru, has appointed Louis Culot as its …
NICE: Cancer Drugs Fund must use our processes
September 3, 2014Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche
NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …
Novo Nordisk scraps inflammatory disorders business
September 2, 2014Research and Development, Sales and Marketing Danish, IL20, Novo Nordisk, diabetes, inflammatory, thomsen
A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …
Fishawack opens US office in San Francisco
September 2, 2014Medical Communications US, comms, communications, fishawack, san francisco
Medical communications firm Fishawack has opened a new office in San Francisco in the US. Under its flagship Fishawack Communications brand …
EMA hires head of comms and HR
September 2, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Manuel Ortigão, Marie-Agnes Heine
The European Medicines Agency has confirmed two new appointments to join its management team. Marie-Agnes Heine (pictured) has joined to …
Children’s cancer death rates drop
September 2, 2014Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, Cancer Research UK, child, death rates
The rate of children dying from cancer has dropped by 22% in the last decade, according to new data published …
Ben Venue problems continue for Boehringer
September 2, 2014Manufacturing and Production, Sales and Marketing Ben Venue, Boehringer, fad, german, manufacturing, recall
Boehringer Ingelheim’s tribulations at its US production site Ben Venue Laboratories are refusing to leave as more of its products …
BioNTech appoints chief financial officer
September 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNTech, Sierk Pötting
German biopharma firm BioNTech has announced that Sierk Pötting will be joining its management team as its chief financial officer, …
NHS proton beam therapy refusal led to child patient disappearance
September 1, 2014Sales and Marketing Ashya King, Cancer, NHS, proton beam
The parents of child cancer patient Ashya King say they took him from hospital because NHS doctors would not offer …
AZ shares climb on positive cancer drug news
September 1, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Pfizer, immunoc-oncology, pd-1
AstraZeneca has moved a key new oncology drug into mid-stage trials as it looks to shore up its cancer research …
China: a dangerous game that pharma must play
September 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, chinese, emerging, market access, pharma, susie lunt
Set to be the biggest country for pharma growth in the 21st century, with rising levels of chronic disease, an …
Novartis heart drug sees stellar results
September 1, 2014Sales and Marketing Diovan, LCZ696, Novartis, failure, heart, valsartan
Novartis’ new heart pill has produced stellar results in helping patients with heart failure live longer, making it the first …
Biogen Idec hires from Novartis to head ALS
September 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Novartis, als, donald johns
Biogen Idec has appointed Dr Donald Johns as the vice president of its amyotrophic lateral sclerosis (ALS) innovation hub unit. …
Janssen: why transparency is essential to the health of our industry
August 29, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency
The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …
Publish all clinical trials, say pharma doctors
August 29, 2014Research and Development, Sales and Marketing Goldacre, all trials, data, fpm, transparency
All clinical trials should be registered and published according to a recent survey conducted by the Faculty of Pharmaceutical Medicine. …
Amgen submits next gen cholesterol drug
August 29, 2014Sales and Marketing Amgen, FDA, PCSK9, Regeneron, Sanofi, statins
Amgen has put itself in pole position in the race to market the next generation of injectable statins known as …
MSC hires new president and chief executive
August 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mary Beth Loesch, msc
US healthcare performance firm Medical Simulation Corporation has confirmed the appointment of Mary Beth Loesch as its president and chief executive. Loesch …
GSK Ebola vaccine fast-tracked into human trials
August 28, 2014Sales and Marketing Africa, Ebola, GSK, WHO, zmapp
GlaxoSmithKline has announced that its experimental Ebola vaccine is being fast-tracked into human studies to help deal with the worst-ever …
Government rips up blank cheque on cancer drugs
August 28, 2014Medical Communications, Sales and Marketing Cancer Drugs Fund, Kadclya, Roche, avastin, sovaldi
Pharma has priced itself out of the Cancer Drugs Fund as the rising costs of its new oncology treatments sees …
Biostar appoints chief scientist
August 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xiaohui Zheng, biostar pharmaceuticals
Chinese manufacturing and marketing firm Biostar Pharmaceuticals has hired professor Xiaohui Zheng as its chief scientist.Zheng is a professor and director of …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
